Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems
Open Access
- 5 December 2022
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 157, 114065
Abstract
No abstract availableKeywords
Funding Information
- Shandong First Medical University (2019QL007)
- Key Technology Research and Development Program of Shandong Province (2019GSF108185)
- Natural Science Foundation of Shandong Province (ZR2020MH200)
This publication has 82 references indexed in Scilit:
- A nanoparticle formula for delivering siRNA or miRNAs to tumor cells in cell culture and in vivoNature Protocols, 2014
- Combination of Dendrimer-Nanovector-Mediated Small Interfering RNA Delivery to Target Akt with the Clinical Anticancer Drug Paclitaxel for Effective and Potent Anticancer Activity in Treating Ovarian CancerJournal of Medicinal Chemistry, 2014
- Mesoporous silica nanoparticles: importance of surface modifications and its role in drug deliveryRSC Advances, 2014
- Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in VivoACS Nano, 2013
- Gold Nanorods Based Platforms for Light-Mediated TheranosticsTheranostics, 2013
- Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer CellsCancer Research, 2012
- Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamersNucleic Acids Research, 2012
- In Vitro Selection of RNA Aptamer and Specific Targeting of ErbB2 in Breast Cancer CellsNucleic Acid Therapeutics, 2011
- Mechanisms of Endocrine Resistance in Breast CancerAnnual Review of Medicine, 2011
- Combination of 3D tissue engineered scaffold and non-viral gene carrier enhance in vitro DNA expression of mesenchymal stem cellsBiomaterials, 2006